Related Experiment Video
Updated: Jun 3, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Hormone therapy in perimenopause and postmenopause (HT). Interdisciplinary S3 Guideline, Association of the
Olaf Ortmann1, Martina Dören, Eberhard Windler
1Department of Gynaecology and Obstetrics, University of Regensburg, Landshuter Straße 65, 93053 Regensburg, Germany. olaf.ortmann@klinik.uni-regensburg.de
Abstract:
This short version of the interdisciplinary S3 guideline on hormone therapy in peri- and postmenopause (HT) is intended as a decision-making instrument for physicians and women considering HT. It is designed to assist daily practice. This short version summarises the long version that contains detailed information about the development of the guideline, particularly about establishing the evidence levels. The statements and recommendations, quoted completely, are marked with the relevant levels of evidence (LoE) and grades of recommendation. The classification system from the Centre for Evidence-based Medicine in Oxford was used in this guideline (see "Attachment").
Related Concept Videos
Menopause
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Regulation
Hormonal Regulation
Therapeutic Drug Monitoring: Affecting Factors
Mitral Valve Prolapse III: Nursing Management